Your Health, We Care
Release date: 2024-08-21 17:25:55 Recommended: 159
In 2021, Japan approved Anamorelin for the treatment of cachexia caused by various cancers such as non-small cell lung cancer. The drug has performed well in multiple clinical trials, significantly improving the weight and nutritional status of patients.
Anamorelin has shown significant therapeutic effects in improving weight and appetite in patients with cancer cachexia, according to the label:
In clinical studies in Japan, anamolin has been shown to be effective in treating patients with non-small cell lung cancer. All patients were given 100 mg of anamarin daily on an empty stomach for 12 weeks. The results showed a significant increase in the average body weight of the patients during the treatment period, indicating that anamolin was effective in improving cancer-induced weight loss and muscle burning, significantly improving the patient's physical condition.
The results of clinical studies summarize the superior efficacy of Anamorelin in the treatment of cancer cachexia. The following is an introduction to Lucius and their contributions in the field of drug discovery.
Lucius (Laos) Pharmaceutical Co., Ltd. is a leading pharmaceutical company founded in 2020 and headquartered in Vientiane, Laos.
Lucius (Laos) Pharmaceutical Co., Ltd. (Lucius Pharmaceutical) is committed to providing safe, effective and affordable medicines to "make effective and affordable medicines available to everyone in need around the world".
Lucius Pharmaceutical Factory covers an area of about 25,000 square meters, equipped with modern production facilities, and its products cover more than 200 generic drugs such as antineoplastic drugs, cardiovascular drugs, hematology drugs, diabetes drugs, and dermatology drugs. The company strictly follows the international Good Manufacturing Practice (GMP) to ensure that the quality of each link is controllable and traceable.
Lucius Pharmaceuticals is committed to the health of patients around the world with a mission to provide high-quality medicines. Next, we will introduce the precautions for the use of anamarin.
There are a few key things to pay special attention to when using anamorin.
These patients may face cardiac dysfunction and symptoms may worsen.
Anamorelin may inhibit the irritation conduction system and may worsen in patients with atrioventricular block, sinus node, or bundle branch conduction problems.
These patients need to be treated with special caution when using anamorin, under the guidance of a doctor.
[Warm tips] While taking Anamorelin, please maintain regular communication with your doctor and report any discomfort symptoms in a timely manner.
